SE8303925D0 - INTERFERON E - Google Patents

INTERFERON E

Info

Publication number
SE8303925D0
SE8303925D0 SE8303925A SE8303925A SE8303925D0 SE 8303925 D0 SE8303925 D0 SE 8303925D0 SE 8303925 A SE8303925 A SE 8303925A SE 8303925 A SE8303925 A SE 8303925A SE 8303925 D0 SE8303925 D0 SE 8303925D0
Authority
SE
Sweden
Prior art keywords
interferon
produced
new
human
cells
Prior art date
Application number
SE8303925A
Other languages
Swedish (sv)
Other versions
SE8303925L (en
Inventor
Jr A P Jarvis
Original Assignee
Damon Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Damon Biotech Inc filed Critical Damon Biotech Inc
Publication of SE8303925D0 publication Critical patent/SE8303925D0/en
Publication of SE8303925L publication Critical patent/SE8303925L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Disclosed is a new material having antiviral activity designated interferon epsilon. The material may be produced, for example, by exposing primary, diploid human eipthelial cells to a virus or certain nucleic acids and then incubating the cells under conditions in which the new interferon is produced and is secreted into the culture medium. The material produced by this process when assayed with cell cultures of human and bovine origin exhibits a unique profile of activity. The material also displays no significant cross reactivity with antisera prepared against either interferon alpha, interferon beta, or interferon gamma in neutralization assays.
SE8303925A 1982-07-12 1983-07-11 INTERFERON E SE8303925L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39761082A 1982-07-12 1982-07-12

Publications (2)

Publication Number Publication Date
SE8303925D0 true SE8303925D0 (en) 1983-07-11
SE8303925L SE8303925L (en) 1984-01-13

Family

ID=23571912

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303925A SE8303925L (en) 1982-07-12 1983-07-11 INTERFERON E

Country Status (12)

Country Link
AU (1) AU573528B2 (en)
BE (1) BE897263A (en)
CH (1) CH664575A5 (en)
DE (1) DE3325131A1 (en)
DK (1) DK319883A (en)
FR (1) FR2531865A1 (en)
GB (1) GB2123835B (en)
IL (1) IL69205A0 (en)
IT (1) IT1203677B (en)
NL (1) NL8302484A (en)
NO (1) NO832517L (en)
SE (1) SE8303925L (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614651A (en) * 1981-07-12 1986-09-30 Damon Biotech, Inc. Interferon epsilon
NL8401911A (en) * 1984-06-15 1986-01-02 Stichting Rega V Z W ANTI-VIRAL PROTEIN, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS PROTEIN.
US4675282A (en) * 1984-07-06 1987-06-23 Damon Biotech, Inc. Assay for interferon epsilon
JP2001526033A (en) 1997-12-08 2001-12-18 ジェネンテク・インコーポレイテッド Human interferon-type I interferon called epsilon
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
CA2342773A1 (en) * 1998-09-18 2000-03-30 Zymogenetics, Inc. Interferon-epsilon
EP1135491A2 (en) * 1998-12-01 2001-09-26 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
CN111420033A (en) * 2020-03-30 2020-07-17 温州肯恩大学(Wenzhou-KeanUniversity) Use of human interferon in tumor treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4016036A (en) * 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
EP0014050A3 (en) * 1979-01-16 1980-10-01 Beecham Group Plc Interferon production
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
JPS56167624A (en) * 1980-05-29 1981-12-23 Toray Ind Inc Method of interferon production

Also Published As

Publication number Publication date
SE8303925L (en) 1984-01-13
GB2123835B (en) 1986-06-18
BE897263A (en) 1983-11-03
IL69205A0 (en) 1983-11-30
IT8367757A0 (en) 1983-07-12
AU573528B2 (en) 1988-06-16
DK319883A (en) 1984-01-13
IT1203677B (en) 1989-02-15
AU1674883A (en) 1984-01-19
NO832517L (en) 1984-01-13
DK319883D0 (en) 1983-07-11
GB8318726D0 (en) 1983-08-10
CH664575A5 (en) 1988-03-15
DE3325131C2 (en) 1987-08-13
NL8302484A (en) 1984-02-01
GB2123835A (en) 1984-02-08
FR2531865A1 (en) 1984-02-24
DE3325131A1 (en) 1984-01-12

Similar Documents

Publication Publication Date Title
YU45871B (en) POLYPEPTIDE WITH HUMAN IMMUNOINTERFERON (IFN-GAMMA) PROPERTIES
DK95687A (en) PROCEDURE FOR CHARGING CULTIVATION OF ANIMAL CELLS
BR8103234A (en) PROCESS OF FERMENTATION OF A SUBSTANCE WITH MICROORGANISMS
BR8201151A (en) PROCESS OF INCLUSION OF MICROORGANISM IN A MATRIX
BR8105993A (en) MICROORGANISM CULTURE AND LIQUID COMPOSITION PROCESS
SE8501534D0 (en) INTERFERON EPSILON
DE69530001D1 (en) IMPROVEMENTS FROM OR IN RELATION TO ENDOMETRIAL FUNCTION
SE8303925D0 (en) INTERFERON E
ES2006714T3 (en) CELL CULTURE SUPPORTS, ETC.
ES8106552A1 (en) Process for propagating human hepatitis A virus in in vitro cell culture.
ATE15693T1 (en) CELL CULTURE PROCEDURE.
MX9273A (en) PROCEDURE FOR THE PREPARATION OF MONOCLONAL ANTIBODIES NEGATIVE ANTIGRAM AND CELL LINE WITH BIOLOGICAL ACTIVITY
ATE41953T1 (en) INCREASED INHIBITION OF YEAST CELL GROWTH.
ES8300853A1 (en) Fixation of spherical microorganism cell
GB2016044B (en) Pretreatment of microcarriers for cell culture
DE3275433D1 (en) Method for culturing non-adhering mammalian cells
IL80901A0 (en) Growth-promoting cell culture medium and process for the cultivation of cells employing the same
FR2582315B1 (en) PROCESS FOR THE CULTURE OF NORMAL EPITHELIAL CELLS
JPS55131387A (en) Cultivation of cell
BG41961A1 (en) Method for cultivating virus of haemorrhagic fever with knidney syndrome on cell cultures
IT8022418A0 (en) DISCONTINUOUS ANAEROBIC DIGESTOR FOR THE PRODUCTION OF BIOGAS AND RELATED PRODUCTION PROCEDURE.
JPS5642583A (en) Surface culturing method and production of dependent substance of cell culture
UA7845A1 (en) Solution for conservation of cell cultures
DE3049825A1 (en) IMMOBILIZED ENZYME (S) AND MICROORGANISM (S) AND THEIR PRODUCTION
ES1003126U (en) Centering device supports urine cultures rectangular section (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8303925-5

Effective date: 19881011

Format of ref document f/p: F